Forbes - ZURICH (Thomson Financial) - Roche Holdings AG said its lung cancer drug Tarceva has been approved in Japan to treat a form of lung cancer which is aggravated following chemotherapy. The drug will be launched in Japan by early 2008. The approval was ...